Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | BHMT | Q93088 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 2/20 | 0.31 |
| ▸ | MMP12 | P39900 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | MVD | P53602 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24065889 | 1.00 | CYP2D6 (0.39) | CYP2D6HIF1ATHRBGMNNTP53 | |
| SCHEMBL9943886 | 0.87 | THRB (0.43) | CYP2D6HIF1ATHRBGMNNTP53 | |
| SCHEMBL7138008 | 0.87 | CYP2D6 (0.32) | CYP2D6HIF1ATHRB | |
| SCHEMBL9943488 | 0.84 | CYP2D6 (0.46) | CYP2D6HIF1ATHRBGMNNTP53 | |
| SCHEMBL23350859 | 0.84 | LMNA (0.50) | THRBHSD17B10BHMTCYP2C19 | |
| SCHEMBL13883931 | 0.84 | LMNA (0.50) | THRBHSD17B10BHMTCYP2C19 | |
| SCHEMBL9943837 | 0.81 | GMNN (0.44) | CYP2D6HIF1ATHRBGMNNTP53 | |
| SCHEMBL9943893 | 0.80 | GMNN (0.47) | CYP2D6HIF1ATHRBGMNNTP53 | |
| SCHEMBL24065969 | 0.80 | KDM1A (0.32) | CES1 | |
| SCHEMBL7723019 | 0.80 | LMNA (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210369846-A1 | New Ammonium Salts Of Fluorinated Organic Acids, Method Of Their Synthesis and Application | NANOSANGUIS (PL) | 2021-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210369846-A1 | New Ammonium Salts Of Fluorinated Organic Acids, Method Of Their Synthesis and Application | APOB, PHOSPHO1, ALB | CYP2D6 1995/4885HIF1A 3583/4885THRB 4071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.